GlassScriptPhysician profile
Deborah A Englert
NPI 1366478224
$43,755.76
in general payments reported to CMS, 2019-2025
39 companies · $3,646 in 2025
The $3,646 reported for 2025 was more than what 87% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $2,069 · 2021: $8,463 · 2022: $4,295 · 2023: $2,744 · 2024: $2,979 · 2025: $3,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,860 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,349.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,859.85 |
| Education | $159.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12,890.40 | 2019-2025 | |
| Allergan, INC. | $9,842.05 | 2021-2023 | |
| Janssen Biotech, INC. | $7,292.61 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Abbvie INC. | $4,063.59 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,954.56 | 2019-2025 | Aklief |
| Regeneron Healthcare Solutions, INC. | $1,028.08 | 2020-2025 | Dupixent |
| Ucb, INC. | $827.00 | 2021-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $500.65 | 2019-2025 | Cabtreo, Arazlo, Siliq |
| Pfizer INC. | $491.55 | 2019-2025 | |
| Lilly USA, LLC | $483.27 | 2019-2025 | Taltz, Ebglyss |
| Incyte Corporation | $473.53 | 2021-2025 | Opzelura |
| Genzyme Corporation | $367.00 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $341.41 | 2023-2025 | Zoryve |
| Janssen Scientific Affairs, LLC | $337.48 | 2019-2022 | |
| Epi Health, LLC | $289.75 | 2019-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Englert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.